Actively hiring
Infectious Disease Therapeutics
Prescription Drugs
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$118.9M
5 rounds on record
Latest round
$78M
Venture round · Oct 2025 · 11 mo ago
Team
16
US Form 5500 (plan participants) · Dec 2025 · +14% in a year
Hiring now
2
open roles
Backers
2
AMR Action Fund, Riverfront Ventures
The money's age
Fresh money
11 months since the last round · hiring slowed
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2025 | $78M | — | PRNewswire |
| Venture round | Dec 2020 | $35.8M | — | SEC Form D |
| Venture round | Aug 2017 | $4M | — | SEC Form D |
| Venture round | May 2017 | $754k | — | SEC Form D |
| Venture round | Jan 2016 | $417k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Peptilogics, Inc. | sec |
Founders and leadersfrom filings, registers and the company's site
Jonathan SteckbeckExecutive Officer, DirectorSEC Form D
Sanjay KakkarExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Our approach enables selective modulation…

Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation adjuvanted subunit vaccines to the market…

Advancing reversible therapies targeting von Willebrand Factor for safer treatment of acute thrombotic conditions. Precision control when…

Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people…

Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of…

LifeMine is a clinical-stage biopharmaceutical company pioneering a bold new approach, Top-Down Drug DiscoveryTM, which leverages…
News
Former President of Depuy Synthes U.S. Joins Peptilogics Board
#top .av-special-heading.av-mmktiypu-699ad5d4b11a8bb90d014b38515c349b{ padding-bottom:10px; } body .av-special-heading.av-mmktiypu-699ad5d4b11a8bb90d014b38515c349b .av-special-heading-tag .heading-char{ font-size:25px; } .av-special-heading.av-mmktiypu-69
Read more
Report
Century Group Sets 2026 AGM to Approve Accounts, Board Slate and Share Mandate
Detailed price information for Abcellera Biologics Inc (ABCL-Q) from The Globe and Mail including charting and trades.
Read more
Report
Peptilogics Begins Pivotal Trial of First-Ever Drug Designed to Cure Medical Device-Related Infections
#top .av-special-heading.av-mmktiypu-b0d707846ebd600d97b636e2f789dc6f{ padding-bottom:10px; } body .av-special-heading.av-mmktiypu-b0d707846ebd600d97b636e2f789dc6f .av-special-heading-tag .heading-char{ font-size:25px; } .av-special-heading.av-mmktiypu-b0
Read more
Report
Report
Peptilogics: $78 Million Raised For Advancing Zaloganan Toward Pivotal Trial For Prosthetic Joint Infections
Peptilogics, a clinical-stage biotechnology company pioneering surgical therapeutics for medical device infections, has closed an oversubscribed $78 million Series B2 financing round. The funding round was led by Presight Capital, Thiel Bio, and Founders
Read more
Report
Pro access
Upgrade to see all 36 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People

Jonathan Steckbeck
Executive Officer, Director

Sanjay Kakkar
Executive Officer, Director

Stephan Dietrich
Director

Stefan Roever
Director

Catherine Mott
Director

Dietrich Stephan
Director

Hannes Holste
Director

Jason Camm
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove
Growth
Hiring Momentum
48/100
Stable
Open positions
2
0 opened / 0 closed in 30 days
ATS activity
Every ~10 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Finance
100% ▼
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Pittsburgh
Pittsburgh
United States
HQ
Pittsburgh
2 open roles 2 posted in 90 days 100% remote 10-50 est. staff
hires for Finance
2681 Sidney Street, Pittsburgh, PA 15203
Financials
Total raised
$118.9M
Latest round
Venture - Series Unknown
Funding rounds
5

AMR Action Fund
Riverfront Ventures